Madhav V. Dhodapkar MBBS
Arthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology; Chief, Section of Hematology, Department of Internal Medicine; Clinical Research Program Leader, Hematology Program, Yale Cancer Center

Departments & Organizations
Biological and Biomedical Sciences (BBS): Immunology | Molecular Medicine, Pharmacology, and PhysiologyYale Medical Group
Cancer Center, Yale: Hematology Program | Cancer Immunology
Immunobiology
Hematology
Biography
Medical School: All India Instt. of Medical Sciences, New Delhi, IndiaFellowship (Hematology / Oncology): Mayo Clinic, Rochester, MN
Prior Faculty appointments: Myeloma Institute, Little Rock, AR; Memorial Sloan Kettering Cancer Center, New York, NY; The Rockefeller University, New York, NY
Research Interests: Immunobiology of myeloma; Development of novel biological approaches to treat cancer; dendritic cell biology
Education
- M.B.B.S., All India Institute of Medical Sciences, New Delhi , 1987
Selected Publication
- Dhodapkar K, Banerjee D, Connolly J, Kukreja A, Matayeva E, Veri MC, Ravetch JV, Steinman RM, Dhodapkar MV. Selective blockade of the inhibitory FC-receptor (Fc-RIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med. 2007, 204: 1359-1369.
Articles

May/June 2008
Expert on myeloma, cancer vaccines to head hematology
Madhav V. Dhodapkar, M.D., an expert on multiple myeloma and monoclonal gammopathy of unknown significance (MGUS), the...
May/June 2010
Immune system fights stem cells’ dark side
If proteins were celebrities, OCT4 would be on the A-list. In 2007, in a dramatic advance, several researchers showed...


